Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
posted on
Mar 26, 2020 01:37PM
But what is said, in the first NR by RVX on March 23, Clearly Stated on its second paragraph that....
"Furthermore, Apabe.. is Known to Inhibit Expression of ACE2, the receptor utilized by the novel coronavirus particles to gain is entery into human cells".
It therefore appears than one part of the story, entery into the cell" has been already known!!!